298 related articles for article (PubMed ID: 25771108)
21. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
22. Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.
Cho JH; Lee MY; Baig IA; Ha NR; Kim J; Yoon MY
Biochimie; 2013 Jul; 95(7):1411-21. PubMed ID: 23523771
[TBL] [Abstract][Full Text] [Related]
23. Bacterial acetohydroxyacid synthase and its inhibitors--a summary of their structure, biological activity and current status.
Gedi V; Yoon MY
FEBS J; 2012 Mar; 279(6):946-63. PubMed ID: 22284339
[TBL] [Abstract][Full Text] [Related]
24. Chlorflavonin Targets Acetohydroxyacid Synthase Catalytic Subunit IlvB1 for Synergistic Killing of Mycobacterium tuberculosis.
Rehberg N; Akone HS; Ioerger TR; Erlenkamp G; Daletos G; Gohlke H; Proksch P; Kalscheuer R
ACS Infect Dis; 2018 Feb; 4(2):123-134. PubMed ID: 29108416
[TBL] [Abstract][Full Text] [Related]
25. Functional evaluation of residues in the herbicide-binding site of Mycobacterium tuberculosis acetohydroxyacid synthase by site-directed mutagenesis.
Jung IP; Cho JH; Koo BS; Yoon MY
Enzyme Microb Technol; 2015 Oct; 78():18-26. PubMed ID: 26215340
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of bacterial acetohydroxyacid synthase (AHAS) and specific inhibitors of Mycobacterium tuberculosis AHAS as potential drug candidates against tuberculosis.
Gokhale K; Tilak B
Curr Drug Targets; 2015; 16(7):689-99. PubMed ID: 25882218
[TBL] [Abstract][Full Text] [Related]
27. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C
J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742
[TBL] [Abstract][Full Text] [Related]
28. Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.
Choi J; Park SJ; Jee JG
Eur J Med Chem; 2015 Dec; 106():157-66. PubMed ID: 26544630
[TBL] [Abstract][Full Text] [Related]
29. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
[TBL] [Abstract][Full Text] [Related]
30. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
[TBL] [Abstract][Full Text] [Related]
31. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
33. Microjaponin, a new dihydroagarofuranoid sesquiterpene from the stem of Microtropis japonica with antituberculosis activity.
Chen JJ; Kuo WL; Chen IS; Peng CF; Sung PJ; Cheng MJ; Lim YP
Chem Biodivers; 2014 Aug; 11(8):1241-6. PubMed ID: 25146767
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and herbicidal activity study of aryl 2,6-disubstituted sulfonylureas as potent acetohydroxyacid synthase inhibitors.
Wei W; Zhou S; Cheng D; Li Y; Liu J; Xie Y; Li Y; Li Z
Bioorg Med Chem Lett; 2017 Aug; 27(15):3365-3369. PubMed ID: 28610985
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of cationic fullerene quinazolinone conjugates and their binding mode with modeled Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase enzyme.
Patel MB; Kumar SP; Valand NN; Jasrai YT; Menon SK
J Mol Model; 2013 Aug; 19(8):3201-17. PubMed ID: 23625031
[TBL] [Abstract][Full Text] [Related]
36. Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2.
Billones JB; Carrillo MC; Organo VG; Macalino SJ; Sy JB; Emnacen IA; Clavio NA; Concepcion GP
Drug Des Devel Ther; 2016; 10():1147-57. PubMed ID: 27042006
[TBL] [Abstract][Full Text] [Related]
37. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of inhibitors of Haemophilus influenzae acetohydroxyacid synthase.
Gedi V; Moon JY; Lim WM; Lee MY; Lee SC; Koo BS; Govindwar S; Yoon MY
Enzyme Microb Technol; 2011 Jun; 49(1):1-5. PubMed ID: 22112263
[TBL] [Abstract][Full Text] [Related]
39. Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents.
Tawari NR; Bag S; Raju A; Lele AC; Bairwa R; Ray MK; Rajan MG; Nawale LU; Sarkar D; Degani MS
Future Med Chem; 2015; 7(8):979-88. PubMed ID: 26062396
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
